VG LIFE SCIENCES INC (OTCMKTS:VGLS) Short Interest Rose By 811.32%

May 3, 2018 - By Maria Fierro

VG Life Sciences Inc. (OTCMKTS:VGLS) Corporate Logo

It was showed an increase on VG LIFE SCIENCES INC (OTCMKTS:VGLS)’s short interest with 811.32%. FINRA issued short interest of VGLS’s total 48,300 shares. Previously was reported up change of 811.32% from 5,300 shares. VG LIFE SCIENCES INC (OTCMKTS:VGLS) has 243,300 shares average volume. It’ll cost 0 days for VGLS to restore its former position.

Lastly it traded at $0.005.It’s since May 3, 2017 and is 0.00% down. The stock underperformed the S&P 500 by 11.55%.

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.The firm is valued at $561,420. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide that is displayed on specific B cells that leads to chronic inflammation.Last it reported negative earnings. The firm also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.